×
For best experience we recommend to activate Javascript in your browser.
IKbIP antibody (AA 132-314)
This Rabbit Polyclonal antibody specifically detects IKbIP in WB, IHC, IP and ICC. It exhibits reactivity toward Human.
Quick Overview for IKbIP antibody (AA 132-314) (ABIN7619782)
Target
See all IKbIP Antibodies
IKbIP
(Inhibitor of KB Kinase beta Interacting Protein (IKbIP))
Reactivity
All reactivities for IKbIP antibodies
Human
Host
All hosts for IKbIP antibodies
Rabbit
Clonality
All clonalities for IKbIP antibodies
Polyclonal
Conjugate
All conjugates for IKbIP antibodies
This IKbIP antibody is un-conjugated
Application
All applications for IKbIP antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-IKbIP Antibody
(hide)
Binding Specificity
All epitopes for IKbIP antibodies
AA 132-314
Purpose
Inhibitor Of Nuclear Factor Kappa B Kinase Interacting Protein (IKBIP) Polyclonal Antibody
Sequence
Trp132~Gln314
Characteristics
The Inhibitor Of Nuclear Factor Kappa B Kinase Interacting Protein (IKBIP) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for IKbIP
(hide)
Target
IKbIP
(Inhibitor of KB Kinase beta Interacting Protein (IKbIP))
Alternative Name
IKBIP
Gene ID
121457
UniProt
Q70UQ0
Recently viewed
(hide)
Chat with us , powered by LiveChat